85 results
8-K
EX-99.1
GRI
GRI Bio Inc
1 Apr 24
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
9:13am
-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking
424B3
GRI
GRI Bio Inc
28 Mar 24
Prospectus supplement
4:45pm
to prioritize the policy issue of “improper” patent listings and whether significant litigation will develop in this area.
When an ANDA applicant submits … to defend the related litigation;
diversion of management’s time and our resources;
substantial monetary awards to trial participants;
product
424B3
GRI
GRI Bio Inc
28 Mar 24
Prospectus supplement
4:42pm
to prioritize the policy issue of “improper” patent listings and whether significant litigation will develop in this area.
When an ANDA applicant submits … to defend the related litigation;
diversion of management’s time and our resources;
substantial monetary awards to trial participants;
product
424B3
GRI
GRI Bio Inc
2 Feb 24
Prospectus supplement
4:25pm
prior to the date that this representation is made.
(m) Litigation. Except as set forth in on Schedule 3.1(m), there is no action, suit, inquiry … ), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation, or (d) in violation
8-K
EX-99.1
3slj61d
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.1
3dt48uunn9g2skn
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.2
vvjrxmu26i h11ka
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
424B4
o7caj z2oj4o
2 Feb 24
Prospectus supplement with pricing info
4:21pm
424B3
68luuvapx77kj74m 9b
30 Jan 24
Prospectus supplement
8:13am
8-K
EX-99.1
uplrw3gy7i5aifyw1
30 Jan 24
GRI Bio Announces Reverse Stock Split
8:12am
8-K
EX-99.1
pef2xj84yfj sf46wz
16 Jan 24
Regulation FD Disclosure
8:45am
424B3
jh3d f1m9k
15 Dec 23
Prospectus supplement
5:02pm
8-K
EX-99.1
fuvuhfsui8xi5v sk
5 Dec 23
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway
9:07am